News and Trends 30 Nov 2018
Update: UK Biotech Scores £5M Series A to Boost Next-Generation Cancer Antibodies
Update (30/11/2018): IGEM Therapeutics has increased the total raised in Series A to £5M (€5.6M) with the participation of two new investors, Alsa Holdings and UCL Technology Fund. The funding will…